Nadeem Q. Mirza
Chief Tech/Sci/R&D Officer at APREA THERAPEUTICS, INC.
Net worth: 45 024 $ as of 2024-03-30
Profile
Dr. Nadeem Q.
Mirza, MD, is a Chief Medical Officer at Aprea Therapeutics, Inc., a Senior Vice President-Clinical Development at Salarius Pharmaceuticals, Inc. and a Head-Oncology & Vice President at Sanofi Oncology.
Dr. Mirza was previously employed as a Senior Vice President-Corporate Medical Affairs by Verastem, Inc. He received his graduate degree from the University of Texas Health Science Center at Houston and a doctorate degree from the University of the Punjab.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
APREA THERAPEUTICS, INC.
0.12% | 2024-04-30 | 6,730 ( 0.12% ) | 45 024 $ | 2024-03-30 |
Nadeem Q. Mirza active positions
| Companies | Position | Start |
|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-07-22 |
| APREA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-04-30 |
Sanofi Oncology
 Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Corporate Officer/Principal | - |
Former positions of Nadeem Q. Mirza
| Companies | Position | End |
|---|---|---|
| VERASTEM, INC. | Corporate Officer/Principal | - |
Training of Nadeem Q. Mirza
| University of the Punjab | Doctorate Degree |
| University of Texas Health Science Center at Houston | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| VERASTEM, INC. | Health Technology |
| SALARIUS PHARMACEUTICALS, INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sanofi Oncology
Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Commercial Services |
- Stock Market
- Insiders
- Nadeem Q. Mirza
